News and Trends 1 Jun 2022 Chinese biotech company looks to help global monkeypox drug development …predicted protein structures are AI-generated, and based on the complete sequence of the genome of the epidemic strain in May 2022, the whole proteome of the 2018 West African virus… June 1, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jul 2023 Existing cancer drug could be repurposed to fight certain aggressive cancers …Loo Lin School of Medicine, both at the National University of Singapore (NUS), and the Genome Institute of Singapore at the Agency for Science, Technology and Research (A*STAR), are seeking… July 10, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2023 Beyond Biotech podcast 35: Rare Disease Day …This year, the day will be marked by more than 600 events in 106 countries. Replay and The University of Texas MD Anderson Cancer Center create Syena Replay, a genome… February 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 …and multinational biopharma Genevant Sciences have agreed to combine Editas’ CRISPR Cas12a genome editing systems with Genevant’s lipid nanoparticle (LNP) technology to develop gene editing medicines. The deal will see… November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Apr 2025 Seven biotechs to watch in the hepatitis B space …gene editing Recent funding: $40 million public offering North Carolina-based company Precision Biosciences is developing its ARCUS genome editing to treat HBV, the first and only clinical-stage gene editing therapy for… April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Feb 2018 This Small Molecule Protects the Muscles of Patients With Duchenne Muscular Dystrophy …for gene therapies to correct errors in the genome. Sarepta, which paid $40M (€33M) upfront and agreed to up to $500M (€407M) in milestones to secure European rights to ezutromid,… February 27, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2022 Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A …base pairs long is common and relatively affordable. However, larger fragments — important for many biotech applications including creating viral genomes, complex pathway engineering, and gene synthesis — are still… February 1, 2022 - 3 minutesmins - By Dan Samorodnitsky Share WhatsApp Twitter Linkedin Email
Expert Advice 12 Mar 2020 Five Challenges For Life Science Marketers in 2020 …was a discussion on personal genetic data with various experts, such as Dawn Barry, founder of LunaPBC, and Aristides Patrinos, former head of the Human Genome Project. On the surface,… March 12, 2020 - 14 minutesmins - By Mark Livingstone Share WhatsApp Twitter Linkedin Email
Opinion 3 Feb 2023 AI and experiments: new possibilities emerge in 2023 …emerge from existing high-quality datasets that were collected in a systematic way (e.g. genome sequences, and protein structures). There are two main misconceptions about today’s generative AI, however: that it… February 3, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jan 2020 10 Scientists Behind Modern Biotech You Probably Don’t Know …the virus being integrated into the animal’s genome, a change that was also passed to the offspring. This technology is now widely used to create mouse models for a wide… January 28, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jun 2022 Upstream Bio to target asthma as it launches with $200M financing …at Human Genome Sciences, MedImmune and Ortho Biotech. Chief business officer Adam Houghton joined Upstream from AbbVie, where he led venture investing and previously had positions at AbbVie and Lilly…. June 2, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Aug 2022 Patient dosed in phase 1 trial evaluating treatment for those with tumors and malignancies …Medicine, said: “In human cells, a variety of repair mechanisms exist to maintain genomic integrity, and defects in these pathways cause genome instability and promote tumorigenesis. “Many cancer cells have… August 16, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email